Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Removed references to multiple myeloma and related MedlinePlus Genetics topics from the page.
    Difference
    0.0%
    Check dated 2026-02-20T14:25:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and included 'MedlinePlus Genetics'; updated page revision from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T11:48:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added new study sites including Sylvester Comprehensive Cancer Center in Coral Gables, FL; Presidente Derqui in Buenos Aires; a site in São Paulo; and Oulu in Finland, increasing the total number of locations to 239. North Ostrobothnia and other entries were removed, resulting in updated regional coverage.
    Difference
    0.9%
    Check dated 2026-02-05T17:30:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Key content mentioning 'Multiple Myeloma' and the MedlinePlus Genetics related topics was removed from the page.
    Difference
    0.0%
    Check dated 2026-01-29T10:06:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Updated recruitment locations to 238 sites, including Buenos Aires, Argentina (B1629AHJ) and São Paulo, Brazil (04537-080), and removed several sites such as Presidente Derqui and Christus St. Vincent Regional Medical Center. MedlinePlus Genetics related topics entry was added.
    Difference
    0.9%
    Check dated 2026-01-15T03:22:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Updated study record dates: primary completion date now 2026-04-27 and enrollment estimated at 944, with the last update posted date shown as 2026-01-07. Some related topics/metadata were removed from the page, including certain 'Multiple myeloma' related topics.
    Difference
    0.1%
    Check dated 2026-01-08T01:57:29.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.